Eyenovia Inc [NASDAQ: EYEN] plunged by -$0.52 during the normal trading session on while it closed the day at $1.76. The company report on March 5, 2024 at 8:00 AM that Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery.
Approval based on nearly 9 out of 10 patients achieving complete absence of post-surgical pain and 6 out of 10 achieving total absence of inflammation within 15 days post-ocular surgery.
Eyenovia plans to launch in the U.S. as soon as this summer using its Mydcombi™ sales force providing pre-surgical pupil dilation and post-surgical care in an estimated $1.3 billion annual U.S. market.
Eyenovia Inc stock has also loss -18.52% of its value over the past 7 days. However, EYEN stock has inclined by 23.08% in the 3 months of the year. Over the past six months meanwhile, it has lost -9.74% and lost -15.38% year-on date.
The market cap for EYEN stock reached $77.65 million, with 36.67 million shares outstanding and 36.00 million shares in the current float. Compared to the average trading volume of 622.69K shares, EYEN reached a trading volume of 4479578 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Eyenovia Inc [EYEN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EYEN shares is $10.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EYEN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Northland Capital have made an estimate for Eyenovia Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 01, 2021. The new note on the price target was released on February 03, 2020, representing the official price target for Eyenovia Inc stock.
The Average True Range (ATR) for Eyenovia Inc is set at 0.25 The Price to Book ratio for the last quarter was 4.78, with the Price to Cash per share for the same quarter was set at 0.47.
EYEN stock trade performance evaluation
Eyenovia Inc [EYEN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.52. With this latest performance, EYEN shares dropped by -2.76% in over the last four-week period, additionally sinking by -9.74% over the last 6 months – not to mention a drop of -44.30% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EYEN stock in for the last two-week period is set at 45.86, with the RSI for the last a single of trading hit 42.18, and the three-weeks RSI is set at 47.81 for Eyenovia Inc [EYEN]. The present Moving Average for the last 50 days of trading for this stock 1.84, while it was recorded at 2.18 for the last single week of trading, and 1.91 for the last 200 days.
Eyenovia Inc [EYEN]: An insightful look at the core fundamentals
Eyenovia Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.49 and a Current Ratio set at 3.50.
Earnings per share (EPS) analysis for Eyenovia Inc [EYEN] stock
With the latest financial reports released by the company, Eyenovia Inc posted -0.17/share EPS, while the average EPS was predicted by analysts to be reported at -0.2/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 15.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EYEN.
Eyenovia Inc [EYEN]: Institutional Ownership
The top three institutional holders of EYEN stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in EYEN stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in EYEN stock with ownership which is approximately 5.8325%.
